These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 33946997)
1. Comparison of Targeted and Untargeted Approaches in Breath Analysis for the Discrimination of Lung Cancer from Benign Pulmonary Diseases and Healthy Persons. Koureas M; Kalompatsios D; Amoutzias GD; Hadjichristodoulou C; Gourgoulianis K; Tsakalof A Molecules; 2021 Apr; 26(9):. PubMed ID: 33946997 [TBL] [Abstract][Full Text] [Related]
2. Confounding effect of benign pulmonary diseases in selecting volatile organic compounds as markers of lung cancer. Wang M; Sheng J; Wu Q; Zou Y; Hu Y; Ying K; Wan H; Wang P J Breath Res; 2018 Sep; 12(4):046013. PubMed ID: 30102249 [TBL] [Abstract][Full Text] [Related]
3. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines. Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150 [TBL] [Abstract][Full Text] [Related]
4. Volatolomics analysis of exhaled breath and gastric-endoluminal gas for distinguishing early upper gastrointestinal cancer from benign. Xiang C; Yang H; Zhao Z; Deng F; Lv Y; Yang Y; Duan Y; Li W; Hu B J Breath Res; 2023 May; 17(3):. PubMed ID: 37094569 [TBL] [Abstract][Full Text] [Related]
5. Study of confounding factors influence on lung cancer diagnostics effectiveness using gas chromatography-mass spectrometry analysis of exhaled breath. Gashimova E; Osipova A; Temerdashev A; Porkhanov V; Polyakov I; Perunov D; Dmitrieva E Biomark Med; 2021 Aug; 15(11):821-829. PubMed ID: 34223778 [No Abstract] [Full Text] [Related]
6. Breath carbonyl compounds as biomarkers of lung cancer. Li M; Yang D; Brock G; Knipp RJ; Bousamra M; Nantz MH; Fu XA Lung Cancer; 2015 Oct; 90(1):92-7. PubMed ID: 26233567 [TBL] [Abstract][Full Text] [Related]
7. Volatile organic compounds in exhaled breath: a promising approach for accurate differentiation of lung adenocarcinoma and squamous cell carcinoma. Li X; Shi L; Long Y; Wang C; Qian C; Li W; Tian Y; Duan Y J Breath Res; 2024 Aug; 18(4):. PubMed ID: 39019071 [TBL] [Abstract][Full Text] [Related]
8. Calculated indices of volatile organic compounds (VOCs) in exhalation for lung cancer screening and early detection. Chen X; Muhammad KG; Madeeha C; Fu W; Xu L; Hu Y; Liu J; Ying K; Chen L; Yurievna GO Lung Cancer; 2021 Apr; 154():197-205. PubMed ID: 33653598 [TBL] [Abstract][Full Text] [Related]
9. Noninvasive detection of lung cancer by analysis of exhaled breath. Bajtarevic A; Ager C; Pienz M; Klieber M; Schwarz K; Ligor M; Ligor T; Filipiak W; Denz H; Fiegl M; Hilbe W; Weiss W; Lukas P; Jamnig H; Hackl M; Haidenberger A; Buszewski B; Miekisch W; Schubert J; Amann A BMC Cancer; 2009 Sep; 9():348. PubMed ID: 19788722 [TBL] [Abstract][Full Text] [Related]
10. Association of Smoking with Metabolic Volatile Organic Compounds in Exhaled Breath. Chen X; Wang F; Lin L; Dong H; Huang F; Ghulam Muhammad K; Chen L; Gorlova OY Int J Mol Sci; 2017 Oct; 18(11):. PubMed ID: 29068415 [TBL] [Abstract][Full Text] [Related]
11. Comparative analyses of volatile organic compounds (VOCs) from patients, tumors and transformed cell lines for the validation of lung cancer-derived breath markers. Filipiak W; Filipiak A; Sponring A; Schmid T; Zelger B; Ager C; Klodzinska E; Denz H; Pizzini A; Lucciarini P; Jamnig H; Troppmair J; Amann A J Breath Res; 2014 Jun; 8(2):027111. PubMed ID: 24862102 [TBL] [Abstract][Full Text] [Related]
12. Diagnosis by Volatile Organic Compounds in Exhaled Breath from Lung Cancer Patients Using Support Vector Machine Algorithm. Sakumura Y; Koyama Y; Tokutake H; Hida T; Sato K; Itoh T; Akamatsu T; Shin W Sensors (Basel); 2017 Feb; 17(2):. PubMed ID: 28165388 [TBL] [Abstract][Full Text] [Related]
13. Application of an artificial neural network model for selection of potential lung cancer biomarkers. Ligor T; Pater Ł; Buszewski B J Breath Res; 2015 May; 9(2):027106. PubMed ID: 25944812 [TBL] [Abstract][Full Text] [Related]
14. Oxidative Stress Biomarkers in Exhaled Breath of Workers Exposed to Crystalline Silica Dust by SPME-GC-MS. Jalali M; Zare Sakhvidi MJ; Bahrami A; Berijani N; Mahjub H J Res Health Sci; 2016; 16(3):153-161. PubMed ID: 27840344 [TBL] [Abstract][Full Text] [Related]
15. Development of an Exhaled Breath Monitoring System with Semiconductive Gas Sensors, a Gas Condenser Unit, and Gas Chromatograph Columns. Itoh T; Miwa T; Tsuruta A; Akamatsu T; Izu N; Shin W; Park J; Hida T; Eda T; Setoguchi Y Sensors (Basel); 2016 Nov; 16(11):. PubMed ID: 27834896 [TBL] [Abstract][Full Text] [Related]
16. Exhaled breath analysis for the discrimination of asthma and chronic obstructive pulmonary disease. Li L; Chen H; Shi J; Chai S; Yan L; Meng D; Cai Z; Guan J; Xin Y; Zhang X; Sun W; Lu X; He M; Li Q; Yan X J Breath Res; 2024 Jul; 18(4):. PubMed ID: 38834048 [TBL] [Abstract][Full Text] [Related]
17. [Measurement of exhaled volatile organic compounds in lung cancer patients]. Lu CR; Hu YJ; Chen EG; Qiu YH; Ying KJ Zhonghua Jie He He Hu Xi Za Zhi; 2010 Feb; 33(2):104-8. PubMed ID: 20367949 [TBL] [Abstract][Full Text] [Related]
18. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study. Westhoff M; Litterst P; Freitag L; Urfer W; Bader S; Baumbach JI Thorax; 2009 Sep; 64(9):744-8. PubMed ID: 19158121 [TBL] [Abstract][Full Text] [Related]
19. Quantitative breath analysis of volatile organic compounds of lung cancer patients. Song G; Qin T; Liu H; Xu GB; Pan YY; Xiong FX; Gu KS; Sun GP; Chen ZD Lung Cancer; 2010 Feb; 67(2):227-31. PubMed ID: 19409642 [TBL] [Abstract][Full Text] [Related]
20. Investigation of lung cancer biomarkers by hyphenated separation techniques and chemometrics. Buszewski B; Ulanowska A; Kowalkowski T; Cieśliński K Clin Chem Lab Med; 2011 Oct; 50(3):573-81. PubMed ID: 22035139 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]